Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
51 /100
HIGH RISK
Score updated Aug 28, 2026

FBIO — Fortress Biotech, Inc. Dilution Risk Tracker

Track FBIO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track FBIO — Get alerts when the score changes →

As of August 28, 2026, Fortress Biotech, Inc. (FBIO) has a DilutionWatch DilutionScore of 51/100, rated HIGH dilution risk. Fortress Biotech, Inc. has a market capitalization of $93.01M, 82.47M shares outstanding, 22 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰Cash Runway
📊 Float Risk
85
⚠️ Warrant Exposure
40
🔄 Convertible Debt
60

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 20%
🔁 Convertible Conversion model 40%
• Significant convertible debt: 16% potential dilution
• Elevated convertible risk (60/100)
🔔 Track FBIO — Get forecast alerts →

Market Data

Market Cap$93.01M
Shares Outstanding82.47M
Float22.38M
Cash$196.58M
Debt$398.0K
Short InterestN/A

Institutional Holdings

22 institutional holders · 534.2K shares
#1 Kestra Advisory Services, LLC 176.0K shares
#2 GEODE CAPITAL MANAGEMENT, LLC 92.8K shares
#3 BlackRock, Inc. 84.7K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest5.78M
Days to Cover12.0
% of Float25.8%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2020-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual FBIO Dilution Snapshot

Fortress Biotech, Inc. (FBIO) has a DilutionScore of 51/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track FBIO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking FBIO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for FBIO
FBIO FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.